- Home
- NNN vs LNTH Comparison
NNN vs LNTH Comparison
Compare NNN & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNN
- LNTH
- Stock Information
- Founded
- NNN 1984
- LNTH 1956
- Country
- NNN United States
- LNTH United States
- Employees
- NNN N/A
- LNTH N/A
- Industry
- NNN Real Estate Investment Trusts
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- NNN Real Estate
- LNTH Health Care
- Exchange
- NNN Nasdaq
- LNTH Nasdaq
- Market Cap
- NNN 7.9B
- LNTH 7.5B
- IPO Year
- NNN N/A
- LNTH 2015
- Fundamental
- Price
- NNN $40.82
- LNTH $78.95
- Analyst Decision
- NNN Hold
- LNTH Strong Buy
- Analyst Count
- NNN 11
- LNTH 5
- Target Price
- NNN $44.70
- LNTH $133.80
- AVG Volume (30 Days)
- NNN 1.2M
- LNTH 1.3M
- Earning Date
- NNN 05-01-2025
- LNTH 05-07-2025
- Dividend Yield
- NNN 5.68%
- LNTH N/A
- EPS Growth
- NNN N/A
- LNTH N/A
- EPS
- NNN 2.14
- LNTH 3.53
- Revenue
- NNN $884,713,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- NNN $4.10
- LNTH $5.81
- Revenue Next Year
- NNN $4.32
- LNTH $12.26
- P/E Ratio
- NNN $19.09
- LNTH $22.69
- Revenue Growth
- NNN 5.40
- LNTH 12.53
- 52 Week Low
- NNN $35.80
- LNTH $74.34
- 52 Week High
- NNN $49.57
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- NNN 45.17
- LNTH 27.93
- Support Level
- NNN $40.21
- LNTH $78.61
- Resistance Level
- NNN $42.50
- LNTH $83.60
- Average True Range (ATR)
- NNN 0.71
- LNTH 3.87
- MACD
- NNN -0.01
- LNTH -3.13
- Stochastic Oscillator
- NNN 26.64
- LNTH 1.12
About NNN NNN REIT Inc.
NNN REIT Inc is a real estate investment trust that invests in and develops properties throughout the United States. The company generates revenue from leasing properties to tenants, including convenience stores, automotive services, fitness centers, theatres, restaurants, and banks. Rents from convenience stores and restaurants contribute the majority proportion of total revenue. The maximum of the company's properties are located in the South and Southeast of the United States.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.